Using Visual Arrays to Support Understanding of Genetic Risk
Examining Genetic Literacy and Numeracy in the General Population
2 other identifiers
interventional
1,045
1 country
1
Brief Summary
The goal of this study is to understand how people understand risk from genetic testing. The investigators want to understand what visual aid best helps people accurately assess risk. The investigators also want to understand how people relate risk to their health. The main questions the study aims to answer are:
- 1.Which visual aid most accurately show genetic risk?
- 2.How do people perceive risk related to genetic test results?
- 3.What factors are associated with people discussing their results with family?
- 4.receive of of two visual aids showing risk
- 5.state their estimation of risk
- 6.answer questions about how they feel about risk and sharing information with family
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2025
CompletedResults Posted
Study results publicly available
September 24, 2026
CompletedSeptember 24, 2026
September 1, 2025
21 days
April 22, 2025
July 10, 2026
August 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perceived Overall Accuracy of General Population Risk for Colorectal Cancer Prior to Seeing Array
Differences between closest approximation to risk percentage depicted in the visual array that depicted risk with Lynch Syndrome (LS) minus risk without LS
immediately after the intervention
Secondary Outcomes (5)
Accuracy of Risk for Colorectal Cancer for Someone Without Lynch Syndrome (Without Gene Mutation) From the Array
immediately after the intervention
Accuracy of Risk for Colorectal Cancer for Someone With Lynch Syndrome From the Array
immediately after the intervention
Risk Perceptions - Percent
baseline
Risk Perceptions - 7-point Likert-type Scale
baseline
Communication Intent
immediately after the intervention
Study Arms (4)
Visual Array & Choice
EXPERIMENTALSingle, side-by-side visual array and non-directive decision frame
Visual Array and Enhanced Choice
EXPERIMENTALSingle, side-by-side visual array and decision frame with subjective norms nudge
Narrative Visual Array and Choice
EXPERIMENTALEvolving narrative showing sequential visual arrays and non-directive decision frame
Narrative Visual Array and Enhanced Choice
EXPERIMENTALEvolving narrative showing sequential visual arrays and decision frame with subjective norms nudge
Interventions
Single side-by-side visual array
Evolving narrative with sequential visual arrays
Decision frame with subjective norms nudge
Eligibility Criteria
You may qualify if:
- ability to read and understand English
- opt-in consent
You may not qualify if:
- incorrect responses to validation questions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston College
Boston, Massachusetts, 02467, United States
Related Publications (1)
Keels JN, Babicheva V, McDonald IR, Witt JK, Dwyer AA. Optimizing Risk Communication for Lynch Syndrome: Results of a Randomized Controlled Trial of Visual Arrays for Genetic Testing. Cancers (Basel). 2026 Apr 25;18(9):1369. doi: 10.3390/cancers18091369.
PMID: 42122165DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Stephanie Seminara
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew A Dwyer, PhD
Boston College
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, MGH Harvard Center for Reproductive Medicine
Study Record Dates
First Submitted
April 22, 2025
First Posted
May 29, 2025
Study Start
July 28, 2025
Primary Completion
August 18, 2025
Study Completion
August 18, 2025
Last Updated
September 24, 2026
Results First Posted
September 24, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Start date: within one month of the publication of study results. End date: one year after posting.
- Access Criteria
- HarvardDataverse platform
Anonymized data will be shared via the HarvardDataverse platform.